TrivarX Limited (ASX:TRI)

Market Cap	17.31M +193.9%
Revenue (ttm)	14.57K -98.6%
Net Income	-8.76M
EPS	-0.96
Shares Out	1.15B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,356,083
Open	0.0140
Previous Close	0.0150
Day's Range	0.0130 - 0.0140
52-Week Range	0.0090 - 0.0350
Beta	0.83
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About TrivarX

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1987
• Employees: 6
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRI

Financial Performance

In fiscal year 2026, TrivarX's revenue was 14,566, a decrease of -98.59% compared to the previous year's 1.03 million. Losses were -8.76 million, 829.0% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 9, 2026

Data Sources Report a data error